Actavis Leads IBD 50 Stocks With Earnings This Week ACT PCYC – Investor’s Business Daily
Actavis Leads IBD 50 Stocks With Earnings This Week ACT PCYCInvestor’s Business DailyThe news followed Monday’s announcement that it will divest the U.S. Rights to the Doryx brand acne treatment to Mayne Pharma for approximately $50 million. Despite these sell-offs, Actavis has been on a buying spree in recent years. It acquired Irish …
[monetize id=”1″]
[monetize id=”2″]
